Hematocrit Test Market is Supposed to Grow at a Healthy CAGR of 4.5% During Forecast 2017-2023
Market Highlights: Hematocrit test is one of the various diagnostic tests used for the diagnosis of anemia, cancer, and kidney diseases. The test measures the percentage of Red Blood Cells (RBCs) in the blood. Low hematocrit levels indicate anemia, cancer, sickle cell anemia, enlarged spleen, and polydipsia. While high hematocrit indicate dehydration, pulmonary embolism, pulmonary fibrosis, Chronic Obstructive Pulmonary Disease (COPD), chronic sleep apnea, and other diseases. Increasing demand for diagnostic medical devices, extensive use of hematocrit test and rising prevalence of cardiovascular diseases, cancer and kidney diseases, are the major drivers for the market growth. Additionally, increasing research and development activities and technological advancements for chronic kidney disease and cancer accelerate the market growth. The global Hematocrit Test Market is expected to grow at a CAGR of 4.5% during the forecast period 2017-2023 Key Players: · ...